Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Interviews

Interview
Treating Chronic Venous Disease With the Venclose Maven™ Perforator Catheter
06/19/2023
VDM spoke with Dr Nathan Tomita about treating patients with chronic venous disease and how the Venclose Maven Perforator Catheter (BD) has given him a modernized, 360° RF solution to treat patients with incompetent perforator veins.
VDM spoke with Dr Nathan Tomita about treating patients with chronic venous disease and how the Venclose Maven Perforator Catheter (BD) has given him a modernized, 360° RF solution to treat patients with incompetent perforator veins.
VDM spoke with Dr Nathan Tomita...
06/19/2023
Vascular Disease Management
Interview
Genicular Artery Embolization in 2023: An Interview With Dr. Osman Ahmed
05/17/2023
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to discuss the latest studies on GAE for OA of the knee and what their results mean for the future of this treatment.
VDM spoke with Dr. Ahmed to...
05/17/2023
Vascular Disease Management
Interview
Dual Therapy Following Iliocaval and Iliofemoral Deep Vein Thrombosis Thrombectomy: An Interview With Dr. Gregg Khodorov
05/17/2023
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month patency.
VDM spoke with Dr. Khodorov to...
05/17/2023
Vascular Disease Management
Interview
Results of the GPX Embolic Device Clinical Trial: An Interview With Dr. Andrew Holden
04/20/2023
At the 2023 Society of Interventional Radiologists Annual Meeting in Phoenix, Arizona, Interventional Radiologist Andrew Holden, ONZM, MBChB, FRANZCR, EBIR, from Auckland City Hospital in New Zealand, presented final results from the GPX...
At the 2023 Society of Interventional Radiologists Annual Meeting in Phoenix, Arizona, Interventional Radiologist Andrew Holden, ONZM, MBChB, FRANZCR, EBIR, from Auckland City Hospital in New Zealand, presented final results from the GPX...
At the 2023 Society of...
04/20/2023
Vascular Disease Management
Interview
Latest Advancements in Coronary Thrombus Removal
04/11/2023
VDM spoke with interventional cardiologist Sanjit Jolly, MD, about the use of thrombectomy devices in PCI, specifically the Indigo® System CAT™ RX (Penumbra) for the removal of emboli and thrombi from the coronary vasculature.
VDM spoke with interventional cardiologist Sanjit Jolly, MD, about the use of thrombectomy devices in PCI, specifically the Indigo® System CAT™ RX (Penumbra) for the removal of emboli and thrombi from the coronary vasculature.
VDM spoke with interventional...
04/11/2023
Vascular Disease Management
Interview
Results of the LAVA Study: An Interview With Dr. Mahmood K. Razavi
03/16/2023
Interventional Radiologist Mahmood K. Razavi, MD, FSIR, talks about results from the Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature (LAVA) study.
Interventional Radiologist Mahmood K. Razavi, MD, FSIR, talks about results from the Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature (LAVA) study.
Interventional Radiologist...
03/16/2023
Vascular Disease Management
Interview
Latest Advancements in Thrombectomy With Lightning Flash
03/09/2023
VDM spoke with vascular surgeon Patrick Muck, MD, about the latest advancements in mechanical thrombectomy and his use of the advanced mechanical thrombectomy system Lightning Flash (Penumbra) for PE.
VDM spoke with vascular surgeon Patrick Muck, MD, about the latest advancements in mechanical thrombectomy and his use of the advanced mechanical thrombectomy system Lightning Flash (Penumbra) for PE.
VDM spoke with vascular surgeon...
03/09/2023
Vascular Disease Management
Interview
Update on the IGuideU Trial: An Interview With Paul Gagne, MD
02/16/2023
At the 2022 VEITH Symposium, Paul Gagne, MD, presented an update on the IGuideU trial, a multi-center, randomized controlled trial to determine if the use of IVUS as an adjunctive imaging modality and as an interventional treatment guide will...
At the 2022 VEITH Symposium, Paul Gagne, MD, presented an update on the IGuideU trial, a multi-center, randomized controlled trial to determine if the use of IVUS as an adjunctive imaging modality and as an interventional treatment guide will...
At the 2022 VEITH Symposium,...
02/16/2023
Vascular Disease Management
Interview
Two-Year Results of the ILLUMINA Study: An Interview With Andrea Kahlberg, MD
01/19/2023
VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.
VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.
VDM speaks with Dr. Andrea...
01/19/2023
Vascular Disease Management
Interview
Simplifying Complex DVT Thrombectomy Cases With the New Protrieve Sheath
01/17/2023
VDM speaks with interventional radiologists Jeffrey Forris Beecham Chick, MD, MPH, and Abdullah Shaikh, MD, about their use of the Protrieve sheath from Inari Medical during complex DVT and IVC thrombectomy cases.
VDM speaks with interventional radiologists Jeffrey Forris Beecham Chick, MD, MPH, and Abdullah Shaikh, MD, about their use of the Protrieve sheath from Inari Medical during complex DVT and IVC thrombectomy cases.
VDM speaks with interventional...
01/17/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement